Stockreport

Pelthos Therapeutics Announces Third Quarter Fiscal 2025 Financial Results

Pelthos Therapeutics Inc.  (PTHS) 
PDF Conference call scheduled for November 13, 2025 at 8:00am ET Commercial launch of ZELSUVMI, the first FDA-approved at-home molluscum contagiosum treatment, exceeded exp [Read more]